Cash flow Immix Biopharma, Inc.

Equities

IMMX

US45258H1068

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-05 pm EST			5-day change	1st Jan Change
5.560 ^USD	+14.88%		+30.82%	+152.73%

Nov. 12	Immix Biopharma, Inc. Appoints Michael Grabow as Chief Commercial Officer	CI
Nov. 07	Immix Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

a14b5f168.SBxq8uC8MXZZpdXdtnHbBITV4_kU8cYasc3Sq4KkhKk.cCVeoa_LASlq3_juwR2_Ue-z1rV3obxX15eam-HI9J8iKDC0gYRwJwHXog

Published financial data: IMMIX BIOPHARMA, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Selling General & Admin Expenses, Total	206K	1.23M	4.02M	7.41M	11.38M
R&D Expenses	105K	127K	4.2M	8.74M	11.29M
Other Operating Expenses, Total	311K	1.35M	8.22M	16.14M	22.67M
Operating Income	-311K	-1.35M	-8.22M	-16.14M	-22.67M
Interest Expense, Total	-102K	-180K	-497	-	-
Interest And Investment Income	-	-	-	572K	1.02M
Net Interest Expenses	-102K	-180K	-497	572K	1.02M
Other Non Operating Income (Expenses)	-574K	-22.76M	-	-	-
EBT, Excl. Unusual Items	-987K	-24.29M	-8.22M	-15.57M	-21.66M
Other Unusual Items	-	-86.17K	-	-	-
EBT, Incl. Unusual Items	-987K	-24.38M	-8.22M	-15.57M	-21.66M
Income Tax Expense	17.55K	6.01K	10.27K	26.42K	41.04K
Earnings From Continuing Operations	-1M	-24.38M	-8.23M	-15.6M	-21.7M
Net Income to Company	-1M	-24.38M	-8.23M	-15.6M	-21.7M
Minority Interest	-	-	-	169K	84.99K
Net Income - (IS)	-1M	-24.38M	-8.23M	-15.43M	-21.61M
Net Income to Common Incl Extra Items	-1M	-24.38M	-8.23M	-15.43M	-21.61M
Net Income to Common Excl. Extra Items	-1M	-24.38M	-8.23M	-15.43M	-21.61M
Per Share Items
Net EPS - Basic	-0.3	-6.64	-0.59	-0.89	-0.76
Basic EPS - Continuing Operations	-0.3	-6.64	-0.59	-0.89	-0.76
Basic Weighted Average Shares Outstanding	3.38M	3.67M	13.89M	17.34M	28.29M
Net EPS - Diluted	-0.3	-6.64	-0.59	-0.89	-0.76
Diluted EPS - Continuing Operations	-0.3	-6.64	-0.59	-0.89	-0.76
Diluted Weighted Average Shares Outstanding	3.38M	3.67M	13.89M	17.34M	28.29M
Normalized Basic EPS	-0.18	-4.13	-0.37	-0.55	-0.48
Normalized Diluted EPS	-0.18	-4.13	-0.37	-0.55	-0.48
Supplemental Items
EBITDA	-308K	-1.35M	-8.22M	-16.14M	-22.64M
EBITA	-311K	-1.35M	-8.22M	-16.14M	-22.67M
EBIT	-311K	-1.35M	-8.22M	-16.14M	-22.67M
EBITDAR	-	-	-	-	-22.42M
Effective Tax Rate - (Ratio)	-1.78	-0.02	-0.12	-0.17	-0.19
Normalized Net Income	-617K	-15.18M	-5.14M	-9.56M	-13.45M
Interest on Long-Term Debt	101K	120K	497	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	206K	1.23M	4.02M	7.41M	11.16M
Research And Development Expense From Footnotes	105K	127K	4.2M	8.74M	11.29M
Net Rental Expense, Total	-	-	-	-	225K
Stock-Based Comp., G&A Exp. (Total)	-	-	524K	2.57M	1.84M
Stock-Based Comp., Other (Total)	-	219K	100K	-	1.18M
Total Stock-Based Compensation	-	219K	624K	2.57M	3.02M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	391K	17.64M	13.44M	17.51M	17.68M
Total Cash And Short Term Investments	391K	17.64M	13.44M	17.51M	17.68M
Other Receivables	297K	25.72K	256K	1.17M	1.97M
Total Receivables	297K	25.72K	256K	1.17M	1.97M
Prepaid Expenses	14.72K	516K	1.21M	1.06M	509K
Other Current Assets, Total	-	-	-	44.58K	32.27K
Total Current Assets	703K	18.19M	14.9M	19.79M	20.2M
Gross Property Plant And Equipment	-	-	-	-	2.78M
Accumulated Depreciation	-	-	-	-	-47.26K
Net Property Plant And Equipment	7.36K	5.7K	3.56K	50.18K	2.73M
Deferred Charges Long-Term	-	-	-	87.23K	-
Other Long-Term Assets, Total	-	-	6.72K	-	20.42K
Total Assets	710K	18.19M	14.91M	19.93M	22.95M
Liabilities
Accounts Payable, Total	263K	143K	1.27M	1.43M	5.39M
Accrued Expenses, Total	343K	9.1K	-	2.29M	3.23M
Short-term Borrowings	4.1M	50K	-	-	-
Current Portion of Leases	-	-	-	-	65.22K
Other Current Liabilities	575K	-	-	-	-
Total Current Liabilities	5.28M	202K	1.27M	3.72M	8.69M
Long-Term Leases	-	-	-	-	1.01M
Other Non Current Liabilities	-	-	475K	-	-
Total Liabilities	5.28M	202K	1.75M	3.72M	9.7M
Common Stock, Total	113	1.32K	1.4K	2K	2.76K
Additional Paid In Capital	509K	47.62M	51.16M	69.78M	88.37M
Retained Earnings	-5.23M	-29.76M	-37.99M	-53.41M	-75.02M
Treasury Stock	-	-	-99.96K	-99.96K	-99.96K
Comprehensive Income and Other	148K	125K	87.02K	135K	-1.06K
Total Common Equity	-4.57M	17.99M	13.16M	16.41M	13.25M
Minority Interest	-	-	-	-202K	-
Total Equity	-4.57M	17.99M	13.16M	16.2M	13.25M
Total Liabilities And Equity	710K	18.19M	14.91M	19.93M	22.95M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.38M	13.86M	13.9M	26.4M	27.72M
ECS Total Common Shares Outstanding	3.38M	13.23M	13.89M	19.92M	27.54M
Book Value / Share	-1.35	1.36	0.95	0.82	0.48
Tangible Book Value	-4.57M	17.99M	13.16M	16.41M	13.25M
Tangible Book Value Per Share	-1.35	1.36	0.95	0.82	0.48
Total Debt	4.1M	50K	0	0	1.07M
Net Debt	3.71M	-17.59M	-13.44M	-17.51M	-16.61M
Debt Equivalent Oper. Leases	-	-	-	-	1.8M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-202K	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	-	-	-	-	849K
Full Time Employees	-	2	9	14	18
Part Time Employees	-	-	2	3	3

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-1M	-24.38M	-8.23M	-15.43M	-21.61M
Depreciation & Amortization - CF	2.32K	2.47K	2.14K	5.47K	115K
Depreciation & Amortization, Total	2.32K	2.47K	2.14K	5.47K	115K
Amortization of Deferred Charges, Total - (CF)	-	58.16K	-	-	-
Stock-Based Compensation (CF)	-	219K	624K	2.57M	3.02M
Other Operating Activities, Total	575K	22.91M	-	-169K	-84.99K
Change In Accounts Payable	6.08K	-106K	1.13M	2.43M	4.4M
Change In Income Taxes	-93.58K	97.67K	-236K	-893K	-972K
Change in Other Net Operating Assets	110K	-383K	-700K	112K	537K
Cash from Operations	-405K	-1.59M	-7.41M	-11.37M	-14.6M
Capital Expenditure	-	-802	-	-52.09K	-1.18M
Cash from Investing	-	-802	-	-52.09K	-1.18M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	200K	-	-	-
Total Debt Issued	-	200K	-	-	-
Short Term Debt Repaid, Total	-	-	-50K	-	-
Total Debt Repaid	-	-	-50K	-	-
Issuance of Common Stock	-	18.65M	2.91M	15.52M	15.95M
Repurchase of Common Stock	-	-	-99.96K	-	-
Other Financing Activities, Total	-	-	468K	-59.62K	-
Cash from Financing	-	18.85M	3.23M	15.46M	15.95M
Foreign Exchange Rate Adjustments	61.77K	-5.43K	-31.52K	33.09K	-3.62K
Miscellaneous Cash Flow Adjustments	-	-	-	-	10
Net Change in Cash	-343K	17.25M	-4.21M	4.07M	172K
Supplemental Items
Cash Interest Paid	899	1.54K	9.6K	-	-
Cash Income Tax Paid (Refund)	17.55K	-	-	-	-
Levered Free Cash Flow	324K	-2.1M	-4.31M	-5.94M	-7.55M
Unlevered Free Cash Flow	388K	-2.04M	-4.31M	-5.94M	-7.55M
Change In Net Working Capital	-579K	1.42M	-202K	-1.63M	-4.66M
Net Debt Issued / Repaid	-	200K	-50K	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-23.5	-9.02	-31.04	-57.92	-66.11
Return on Total Capital	2.23K	-9.71	-32.93	-68.71	-92.84
Return On Equity %	24.46	-367.8	-52.84	-106.22	-147.33
Return on Common Equity	24.46	-367.8	-52.84	-104.35	-145.76
Short Term Liquidity
Current Ratio	0.13	90.01	11.7	5.32	2.33
Quick Ratio	0.13	87.46	10.75	5.02	2.26
Operating Cash Flow to Current Liabilities	-0.08	-7.87	-5.82	-3.06	-1.68
Long Term Solvency
Total Debt/Equity	-89.69	0.28	-	-	8.11
Total Debt / Total Capital	-870.36	0.28	-	-	7.5
LT Debt/Equity	-	-	-	-	7.62
Long-Term Debt / Total Capital	-	-	-	-	7.05
Total Liabilities / Total Assets	743.67	1.11	11.73	18.68	42.26
EBIT / Interest Expense	-3.05	-7.52	-16.54K	-	-
EBITDA / Interest Expense	-3.02	-7.5	-16.53K	-	-
(EBITDA - Capex) / Interest Expense	-3.02	-7.51	-16.53K	-	-
Total Debt / EBITDA	-13.29	-0.04	-	-	-0.05
Net Debt / EBITDA	-12.02	13.04	1.64	1.09	0.74
Total Debt / (EBITDA - Capex)	-13.29	-0.04	-	-	-0.05
Net Debt / (EBITDA - Capex)	-12.02	13.03	1.64	1.08	0.7
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	-63.34	198.88	508.86	96.37	40.32
EBITA, 1 Yr. Growth %	-63.11	197.9	507.9	96.39	40.48
EBIT, 1 Yr. Growth %	-63.11	197.9	507.9	96.39	40.48
Earnings From Cont. Operations, 1 Yr. Growth %	3.29	2.02K	-66.25	89.5	39.13
Net Income, 1 Yr. Growth %	3.29	2.02K	-66.25	87.44	40.11
Normalized Net Income, 1 Yr. Growth %	3.67	2.05K	-66.16	86.12	40.68
Diluted EPS Before Extra, 1 Yr. Growth %	3.29	1.85K	-91.07	50.11	-14.1
Net Property, Plant and Equip., 1 Yr. Growth %	-23.97	-22.63	-37.49	1.31K	5.34K
Total Assets, 1 Yr. Growth %	-24.69	3.27K	-18.05	33.65	15.17
Tangible Book Value, 1 Yr. Growth %	25.36	-480.29	-26.85	24.66	-19.23
Common Equity, 1 Yr. Growth %	25.36	-480.29	-26.85	24.66	-19.23
Cash From Operations, 1 Yr. Growth %	-48.78	292.72	366.13	53.5	28.35
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	2.16K
Levered Free Cash Flow, 1 Yr. Growth %	-	-632.49	105.43	37.8	27.18
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-546.48	110.87	37.81	27.18
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	26.64	326.59	245.78	66
EBITA, 2 Yr. CAGR %	-	26.68	325.55	245.52	66.1
EBIT, 2 Yr. CAGR %	-	26.68	325.55	245.52	66.1
Earnings From Cont. Operations, 2 Yr. CAGR %	-	400.65	167.76	-20.03	62.38
Net Income, 2 Yr. CAGR %	-	400.65	167.76	-20.46	62.06
Normalized Net Income, 2 Yr. CAGR %	-	405.07	169.66	-20.64	61.81
Diluted EPS Before Extra, 2 Yr. CAGR %	-	379.94	32	-63.4	13.55
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-23.31	-30.46	196.84	2.67K
Total Assets, 2 Yr. CAGR %	-	339.24	425.63	4.65	24.07
Tangible Book Value, 2 Yr. CAGR %	-	122.12	66.79	-4.51	0.35
Common Equity, 2 Yr. CAGR %	-	122.12	66.79	-4.51	0.35
Cash From Operations, 2 Yr. CAGR %	-	41.83	327.85	167.49	40.36
Capital Expenditures, 2 Yr. CAGR %	-	-66.87	-	705.91	-
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	230.74	68.25	32.38
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	206.83	70.47	32.39
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	113.75	229.38	156
EBITA, 3 Yr. CAGR %	-	-	113.67	228.86	155.97
EBIT, 3 Yr. CAGR %	-	-	113.67	228.86	155.97
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	103.76	138.62	-3.81
Net Income, 3 Yr. CAGR %	-	-	103.76	137.75	-3.94
Normalized Net Income, 3 Yr. CAGR %	-	-	105.13	138.31	-3.96
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	27.16	37.78	-51.36
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-28.36	89.61	682.59
Total Assets, 3 Yr. CAGR %	-	-	150.98	233	8.05
Tangible Book Value, 3 Yr. CAGR %	-	-	53.39	51.36	-9.69
Common Equity, 3 Yr. CAGR %	-	-	53.39	51.36	-9.69
Cash From Operations, 3 Yr. CAGR %	-	-	110.87	204.02	109.41
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	1.04K
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	147.02	53.26
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	134.98	54.61
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	-	93.19
EBITA, 5 Yr. CAGR %	-	-	-	-	93.19
EBIT, 5 Yr. CAGR %	-	-	-	-	93.19
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	86.07
Net Income, 5 Yr. CAGR %	-	-	-	-	85.93
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	86.56
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	21.53
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	209.05
Total Assets, 5 Yr. CAGR %	-	-	-	-	89.34
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	29.44
Common Equity, 5 Yr. CAGR %	-	-	-	-	29.44
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	79.19
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	176.34